{"url":"https://lda.senate.gov/api/v1/filings/b35d3a87-a567-4d52-a4f5-e372589b5cd5/","filing_uuid":"b35d3a87-a567-4d52-a4f5-e372589b5cd5","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2021,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/b35d3a87-a567-4d52-a4f5-e372589b5cd5/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Robert L. Livingston","dt_posted":"2021-07-19T11:22:23.207000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"499 S. CAPITOL STREET, S.W.","registrant_address_2":"SUITE 600","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20003","registrant":{"id":49635,"url":"https://lda.senate.gov/api/v1/registrants/49635/","house_registrant_id":34606,"name":"THE LIVINGSTON GROUP, LLC","description":"Government and Public Relations consultants","address_1":"425 3RD ST SW","address_2":"SUITE 1250","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ROBERT L. LIVINGSTON","contact_telephone":"+1 202-289-9881","dt_updated":"2026-07-10T14:52:56.951258-04:00"},"client":{"id":207024,"url":"https://lda.senate.gov/api/v1/clients/207024/","client_id":1005561,"name":"LAKEPHARMA, INC.","general_description":"Biologics service provider","client_government_entity":false,"client_self_select":null,"state":"TX","state_display":"Texas","country":"US","country_display":"United States of America","ppb_state":"TX","ppb_state_display":"Texas","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-09-14"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"COVID-19 countermeasures\nContinued implementation of (1) H.R. 748, The Coronavirus Aid, Relief, and Economic Security (CARES) Act (2020),(2) H.R. 133, the Coronavirus Response and Consolidated Appropriations Act (2021), and (3) H.R. 1319, American Rescue Plan Act (2021).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":40853,"prefix":null,"prefix_display":null,"first_name":"ROBERT","nickname":null,"middle_name":"L","last_name":"LIVINGSTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":42697,"prefix":null,"prefix_display":null,"first_name":"J","nickname":null,"middle_name":"ALLEN","last_name":"MARTIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":14319,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"CAMBON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":15289,"prefix":null,"prefix_display":null,"first_name":"BERNIE","nickname":null,"middle_name":null,"last_name":"ROBINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63788,"prefix":null,"prefix_display":null,"first_name":"BRIAN","nickname":null,"middle_name":null,"last_name":"GLACKIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":40746,"prefix":null,"prefix_display":null,"first_name":"CATHRYN","nickname":null,"middle_name":"J","last_name":"KINGSBURY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}